Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

1.

Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation.

Ware K, Brodsky P, Satoskar AA, Nadasdy T, Nadasdy G, Wu H, Rovin BH, Bhatt U, Von Visger J, Hebert LA, Brodsky SV.

J Am Soc Nephrol. 2011 Oct;22(10):1856-62. doi: 10.1681/ASN.2010101110. Epub 2011 Sep 1.

PMID:
21885669
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy.

Ozcan A, Ware K, Calomeni E, Nadasdy T, Forbes R, Satoskar AA, Nadasdy G, Rovin BH, Hebert LA, Brodsky SV.

Am J Nephrol. 2012;35(4):356-64. doi: 10.1159/000337918. Epub 2012 Apr 2.

PMID:
22473220
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

N-acetylcysteine ameliorates acute kidney injury but not glomerular hemorrhage in an animal model of warfarin-related nephropathy.

Ware K, Qamri Z, Ozcan A, Satoskar AA, Nadasdy G, Rovin BH, Hebert LA, Nadasdy T, Brodsky SV.

Am J Physiol Renal Physiol. 2013 Jun 15;304(12):F1421-7. doi: 10.1152/ajprenal.00689.2012. Epub 2013 Apr 10.

PMID:
23576637
[PubMed - indexed for MEDLINE]
Free Article
4.

Warfarin-related nephropathy is the tip of the iceberg: direct thrombin inhibitor dabigatran induces glomerular hemorrhage with acute kidney injury in rats.

Ryan M, Ware K, Qamri Z, Satoskar A, Wu H, Nadasdy G, Rovin B, Hebert L, Nadasdy T, Brodsky SV.

Nephrol Dial Transplant. 2014 Dec;29(12):2228-34. doi: 10.1093/ndt/gft380. Epub 2013 Sep 5.

PMID:
24009280
[PubMed - in process]
5.

Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate.

Brodsky SV, Nadasdy T, Rovin BH, Satoskar AA, Nadasdy GM, Wu HM, Bhatt UY, Hebert LA.

Kidney Int. 2011 Jul;80(2):181-9. doi: 10.1038/ki.2011.44. Epub 2011 Mar 9.

PMID:
21389969
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases.

Brodsky SV, Satoskar A, Chen J, Nadasdy G, Eagen JW, Hamirani M, Hebert L, Calomeni E, Nadasdy T.

Am J Kidney Dis. 2009 Dec;54(6):1121-6. doi: 10.1053/j.ajkd.2009.04.024. Epub 2009 Jul 4.

PMID:
19577348
[PubMed - indexed for MEDLINE]
7.

An unusual cause of glomerular hematuria and acute kidney injury in a chronic kidney disease patient during warfarin therapy.

Santos C, Gomes AM, Ventura A, Almeida C, Seabra J.

Nefrologia. 2013;33(3):400-3. doi: 10.3265/Nefrologia.pre2012.Oct.11617. English, Spanish.

PMID:
23712226
[PubMed - indexed for MEDLINE]
Free Article
8.

Reductions in renal mass and the nephropathy induced by mercury.

Zalups RK.

Toxicol Appl Pharmacol. 1997 Apr;143(2):366-79.

PMID:
9144453
[PubMed - indexed for MEDLINE]
9.

The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat.

Vogelbacher R, Wittmann S, Braun A, Daniel C, Hugo C.

Transplantation. 2007 Dec 15;84(11):1492-9.

PMID:
18091526
[PubMed - indexed for MEDLINE]
10.
11.

Warfarin therapy that results in an International Normalization Ratio above the therapeutic range is associated with accelerated progression of chronic kidney disease.

Brodsky SV, Collins M, Park E, Rovin BH, Satoskar AA, Nadasdy G, Wu H, Bhatt U, Nadasdy T, Hebert LA.

Nephron Clin Pract. 2010;115(2):c142-6. doi: 10.1159/000312877. Epub 2010 Apr 22.

PMID:
20413993
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Apoptosis and expression of Bax protein and Fas antigen in glomeruli of a remnant-kidney model.

Hattori T, Shindo S, Kawamura H.

Nephron. 1998;79(2):186-91.

PMID:
9647499
[PubMed - indexed for MEDLINE]
13.
14.

[Progressive glomerular sclerosis and renal failure in rat with 7/8 nephrectomy model].

Makino H, Theng LZ, Kumagai I, Takatori K, Ota Z, Yoshifusa H.

Nihon Jinzo Gakkai Shi. 1990 Feb;32(2):127-36. Japanese.

PMID:
2352356
[PubMed - indexed for MEDLINE]
15.

Acute CdMT injection is not a good model to study chronic Cd nephropathy: comparison of chronic CdCl2 and CdMT exposure with acute CdMT injection in rats.

Liu J, Habeebu SS, Liu Y, Klaassen CD.

Toxicol Appl Pharmacol. 1998 Nov;153(1):48-58.

PMID:
9875299
[PubMed - indexed for MEDLINE]
16.

Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis.

Naito T, Ma LJ, Yang H, Zuo Y, Tang Y, Han JY, Kon V, Fogo AB.

Am J Physiol Renal Physiol. 2010 Mar;298(3):F683-91. doi: 10.1152/ajprenal.00503.2009. Epub 2009 Dec 30.

PMID:
20042458
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat.

Kuhlmann A, Haas CS, Gross ML, Reulbach U, Holzinger M, Schwarz U, Ritz E, Amann K.

Am J Physiol Renal Physiol. 2004 Mar;286(3):F526-33. Epub 2003 Nov 4.

PMID:
14600034
[PubMed - indexed for MEDLINE]
Free Article
18.

V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.

Perico N, Zoja C, Corna D, Rottoli D, Gaspari F, Haskell L, Remuzzi G.

Kidney Int. 2009 Nov;76(9):960-7. doi: 10.1038/ki.2009.267. Epub 2009 Jul 22.

PMID:
19625993
[PubMed - indexed for MEDLINE]
19.

Evidence of tubular hypoxia in the early phase in the remnant kidney model.

Manotham K, Tanaka T, Matsumoto M, Ohse T, Miyata T, Inagi R, Kurokawa K, Fujita T, Nangaku M.

J Am Soc Nephrol. 2004 May;15(5):1277-88.

PMID:
15100368
[PubMed - indexed for MEDLINE]
Free Article
20.

Atubular glomeruli, renal function and hypertrophic response in rats with chronic lithium nephropathy.

Marcussen N, Christensen S, Petersen JS, Shalmi M.

Virchows Arch A Pathol Anat Histopathol. 1991;419(4):281-9.

PMID:
1949611
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk